No Picture
News

Poseida Therapeutics Reports Operational Update and Financial Results for Second Quarter and First Half of 2020

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Poseida Therapeutics, Inc. (Nasdaq: PSTX), a clinical-stage biopharmaceutical company utilizing proprietary gene engineering platform technologies to create cell and gene therapeutics with the capacity to cur… […]

No Picture
News

Kintara Therapeutics (Formerly DelMar Pharmaceuticals) Announces Completion of Merger with Adgero Biopharmaceuticals and Closing of $19.6 Million Private Placement Priced At-The-Market

– DelMar Pharmaceuticals, Inc. Name Change to Kintara Therapeutics, Inc.- Kintara Therapeutics to Trade on Nasdaq Capital Market under the Ticker Symbol “KTRA”

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Kintara Therapeutics, Inc. (formerly DelMar Pharm… […]

No Picture
News

Qualigen Therapeutics Announces Issuance of STARS(TM) Technology Patent by the U.S. Patent and Trademark Office

CARLSBAD, Calif., Aug. 20, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) announced today that the United States Patent and Trademark Office has issued patent No. 10,744,257 entitled “Devices and Methods f… […]

No Picture
News

Viking Therapeutics to Present New Data from Phase 2 Study of VK2809 in Patients with Non-Alcoholic Fatty Liver Disease (NAFLD) and Elevated LDL-Cholesterol at The Digital International Liver Congress(TM) 2020

Oral Presentation to Highlight New Efficacy Data Measured at Week 16 and Additional Week 12 Efficacy Data Stratified by Baseline Characteristics and Risk Factors

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — Viking Therapeutics, Inc. (Viking) (NASDAQ: VKT… […]

No Picture
News

Low-Cost Nafamostat Blocks SARS-CoV-2 Infection in Human Lung Cells, Preclinical Study Finds

Covistat repurposing generic pancreatitis remedy for oral, inhaled COVID-19 treatments

SAN DIEGO, Aug. 20, 2020 /PRNewswire/ — A preclinical study testing the low-cost generic drug nafamostat in human cells shows it can help block SARS-CoV-2 infecti… […]

No Picture
News

Biocept Awarded US Patent for proprietary Primer-Switch Mutation Detection and Amplification Improvement Platform Used to Detect Rare Cell Mutations, Including Cancer Biomarkers

Expands Company’s patent portfolio and marks another step in pursuit of worldwide intellectual property protection for proprietary Primer-Switch technology used to detect rare events such as cancer biomarkers found in tissue and liquid biopsies

SAN … […]

No Picture
News

Thermo Fisher Scientific Signs Companion Diagnostic Agreement with Hengrui Therapeutics, Inc.

Companion diagnostic will leverage the Oncomine Precision Assay to identify non-small cell lung cancer patients who may benefit from pyrotinib

CARLSBAD, Calif., Aug. 17, 2020 /PRNewswire/ — Thermo Fisher Scientific has signed a companion diagnostic … […]

No Picture
News

Qualigen Therapeutics Announces Business Highlights and First Quarter Fiscal Year 2021 Financial Results; Has $16 Million in Cash on Hand as of Today

CARLSBAD, Calif., Aug. 14, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (Qualigen or the Company) today announced business highlights and financial results for the fiscal year 2021 first quarter, ended June 30, 2020.
Business hig… […]

No Picture
News

ImmunoScape Targets Immunology Breakthroughs for COVID-19 and Oncology with $11M in Global Financing Led by Anzu Partners and UTEC

The funds enable ImmunoScape to bring its unique immune-profiling capability to major biopharma companies globally, accelerating development of vital immunotherapies and other medicines

SINGAPORE and SAN DIEGO, Aug. 12, 2020 /PRNewswire/ — ImmunoSc… […]

No Picture
News

Eclipse Cofounders Publish Foundational Dataset Revealing Extensive Hidden Signals in Human Genes

eCLIP technology solved key problem in matching hundreds of RNA binding proteins to the instruction signals within the RNA code to uncover how RNA binding proteins regulate gene expression

SAN DIEGO, Aug. 11, 2020 /PRNewswire/ — Eclipse Bioinno… […]

No Picture
News

Tarsus Pharmaceuticals Welcomes Aziz Mottiwala as Chief Commercial Officer and Relocates to Larger Irvine Headquarters

Mr. Mottiwala Brings over 20 Years of Biopharmaceutical Experience to Growing Tarsus Leadership Team

ORANGE COUNTY, Calif., Aug. 11, 2020 /PRNewswire/ — Tarsus Pharmaceuticals, a late clinical-stage biopharmaceutical company, today announced the app… […]

No Picture
News

Puradigm, LLC announces successful tests of its proactive air and surface purification technology in deactivating SARS-CoV-2, the virus that causes COVID-19, as well as deactivating coronavirus 229E

Results from a study done by the University of Florida using the SARS-CoV-2 virus show a significant decrease in infectivity of the virus immediately after exposure to Puradigm’s technology and show the virus was undetectable after 24 hours of expos… […]

No Picture
News

Mirati Therapeutics Reports Second Quarter 2020 Financial Results And Recent Business Highlights

SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — Mirati Therapeutics, Inc. (NASDAQ: MRTX), a clinical-stage targeted oncology company, today reported financial results and a corporate update for the second quarter ended June 30, 2020.
“Mirati is working to d… […]

No Picture
News

Covistat, Biopharmaceutical Company Developing Low-Cost COVID-19 Treatment, Acquires IP From World Leader in Respiratory Disease Medicine

Technology, expertise from UK’s Mucokinetica to accelerate repurposing of generic remedy nafamostat for COVID-19 oral, inhalation therapy

SAN DIEGO, Aug. 6, 2020 /PRNewswire/ — A biopharmaceutical company repurposing nafamostat, a generic remedy for… […]

No Picture
News

Heron Therapeutics Announces Financial Results for the Three and Six Months Ended  June 30, 2020 and Highlights Recent Corporate Updates

SAN DIEGO, Aug. 5, 2020 /PRNewswire/ — Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best–in-class treatments to address some of the most important unmet p… […]

No Picture
News

Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

CARLSBAD, Calif., Aug. 4, 2020 /PRNewswire/ — Qualigen Therapeutics, Inc. (NASDAQ: QLGN) (“Qualigen” or the “Company”), today announced the closing of its previously announced registered direct offering, priced at-the-market under Nasdaq rules, wit… […]

No Picture
News

HUYA Bioscience International Licenses the Novel SHP2 Inhibitor HBI-2376 for Development in Oncology

 SAN DIEGO, Aug. 4, 2020 /PRNewswire/ — HUYA Bioscience International (HUYABIO

®
), the leader in accelerating global development of China’s pharmaceutical innovations, announced today it has exclusively licensed worldwide rights, … […]

No Picture
News

Evofem Biosciences Reports Second Quarter 2020 Financial Results and Provides Corporate Update

– Advancing Precommercial Activities in Preparation for Phexxi(TM) Commercial Launch in September 2020 — Pivotal Phase 3 Trial of EVO100 for Prevention of Chlamydia and Gonorrhea on Track for Q4 2020 Initiation — Management to Host Conference Call Tu… […]